A preliminary report on stem cell therapy for neuropathic pain in humans

201479 citationsJournal Articlegold Open Access

Authors

Elisabeth Karsten · Engeneic (Australia)

Richard Lilischkis · Engeneic (Australia)

John Flood · St Vincent's Hospital Sydney

Abstract

This preliminary open-labeled study showed autologous administration of stem cells for neuropathic trigeminal pain significantly reduced pain intensity at 6 months and is a safe and well tolerated intervention.

Topics & Keywords

Nerve injury and regeneration Pain Mechanisms and Treatments Pain Management and Placebo Effect

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Pain Research

Volume 7, pp. 255-255

DOI: 10.2147/jpr.s63361

Field-Weighted Citation Impact: 2.02